Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To obtain quantitative neurometabolite measurements, specifically myoinositol (mI) and glutamate plus glutamine (Glx), markers of glial and neuronal excitation, in deep gray matter structures after mild traumatic brain injury (mTBI) using proton magnetic resonance spectroscopy (1H-MRS) and to compare these measurements against normal healthy control subjects.
Methods: This study approved by the institutional review board is Health Insurance Portability and Accountability Act compliant. T1-weighted MRI and multi-voxel 1H-MRS imaging were acquired at 3 tesla from 26 patients with mTBI an average of 22 days postinjury and from 13 age-matched healthy controls. Two-way analysis of variance was used to compare patients and controls for mean N-acetylaspartate, choline, creatine (Cr), Glx, and mI levels as well as the respective ratios to Cr within the caudate, globus pallidus, putamen, and thalamus.
Results: Quantitative putaminal mI was higher in patients with mTBI compared with controls (p = 0.02). Quantitative neurometabolite ratios of putaminal mI and Glx relative to Cr, mI/Cr, and Glx/Cr were also higher among patients with mTBI compared with controls (p = 0.01 and 0.02, respectively). No other differences in neurometabolite levels or ratios were observed in any other brain region evaluated.
Conclusion: Increased putaminal mI, mI/Cr, and Glx/Cr in patients after mTBI compared with control subjects supports the notion of a complex glial and excitatory response to injury without concomitant neuronal loss, evidenced by preserved N-acetylaspartate levels in this region.
GLOSSARY
- ANCOVA=
- analysis of covariance;
- Cho=
- choline;
- Cr=
- creatine;
- FLAIR=
- fluid-attenuated inversion recovery;
- FOV=
- field of view;
- GCS=
- Glasgow Coma Scale;
- Glx=
- glutamate plus glutamine;
- 1H-MRS=
- proton magnetic resonance spectroscopy;
- IS=
- inferior-superior;
- mI=
- myoinositol;
- MP-RAGE=
- magnetization-prepared rapid-acquisition gradient echo;
- mTBI=
- mild traumatic brain injury;
- NAA=
- N-acetylaspartate;
- ROI=
- region of interest;
- TBI=
- traumatic brain injury;
- TE=
- echo time;
- TR=
- repetition time;
- VOI=
- volume of interest
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received June 26, 2013.
- Accepted in final form November 1, 2013.
- © 2014 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
The Toronto traumatic brain injury studyInjury severity and quantified MRIB. Levine, N. Kovacevic, E. I. Nica et al.Neurology, March 03, 2008 -
Research Article
White Matter Disruption in Pediatric Traumatic Brain InjuryResults From ENIGMA Pediatric Moderate to Severe Traumatic Brain InjuryEmily L. Dennis, Karen Caeyenberghs, Kristen R. Hoskinson et al.Neurology, May 28, 2021 -
Articles
MRS in presymptomatic MAPT mutation carriersA potential biomarker for tau-mediated pathologyK. Kantarci, B.F. Boeve, Z.K. Wszolek et al.Neurology, August 30, 2010 -
Articles
A multicenter 1H-MRS study of the medial temporal lobe in AD and MCIF. Jessen, O. Gür, W. Block et al.Neurology, May 18, 2009


